drugset / Trial / NCT00063362
Combination Therapy for the Treatment of Bipolar Disorders
Phase 3
Terminated
49 enrolled
University Hospitals Cleveland Medical Center
National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will compare triple and double drug regimens in the treatment of patients with depression, hypomania, or mania.
Timeline
- Start
- 2002-02
- Primary completion
- 2007-07
- Completion
- 2007-07
Outcome
Outcome not reported
Stopped (Business): “Funding Expiration”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lamotrigine | Small molecule | 150 mg | — |
| Subject | Lamotrigine | Small molecule | 200 mg | — |
| Background | Divalproex Sodium | Small molecule | 250 mg | — |
| Background | Lithium | Unknown | 450 mg | — |